{"id":833873,"date":"2025-04-03T18:24:15","date_gmt":"2025-04-03T22:24:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/"},"modified":"2025-04-03T18:24:15","modified_gmt":"2025-04-03T22:24:15","slug":"mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/","title":{"rendered":"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; MRVI"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">LOS ANGELES<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">April 3, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4398591-1&amp;h=3883274483&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4249451-1%26h%3D2037481888%26u%3Dhttps%253A%252F%252Fdjslawllp.com%252F%26a%3DThe%2BDJS%2BLaw%2BGroup&amp;a=The+DJS+Law+Group\" target=\"_blank\" rel=\"nofollow\">The DJS Law Group<\/a>\u00a0reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (&#8220;Maravai&#8221; or &#8220;the Company&#8221;) (NASDAQ: MRVI) for violations of the federal securities laws.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2657850\/DJS.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2657850\/DJS.jpg\" title=\"DJS Law Group\" alt=\"DJS Law Group\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Shareholders who purchased the Company&#8217;s securities between <span class=\"xn-chron\">August 7, 2024<\/span> and <span class=\"xn-chron\">February 24, 2025<\/span>, inclusive (the &#8220;Class Period&#8221;), are encouraged to contact the firm before <span class=\"xn-chron\">May 5<\/span>, 2025.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>\n        <b>CASE DETAILS:<\/b>\u00a0\u00a0The complaint <span>alleges<\/span> that the Company made false and misleading statements to the market concerning whether Maravai failed to maintain adequate internal controls over financial reporting. The Company improperly recognize revenue from certain transactions in fiscal 2024. The Company also <span>allegedly<\/span> overstated its goodwill.<\/p>\n<p>If you are a shareholder who suffered a loss,\u00a0<a href=\"mailto:David@djslawllp.com\" target=\"_blank\" rel=\"nofollow\">contact us to participate<\/a>.<\/p>\n<p>\n        <b>WHY DJS LAW GROUP?<\/b>\u00a0DJS Law Group&#8217;s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&amp;A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n<p>\n        <b>CONTACT:<br \/><\/b><br \/>\n        <span class=\"xn-person\">David J. Schwartz<\/span><br \/>\n        <br \/>DJS Law Group<br \/>274 White Plains Road, Suite 1<br \/><span class=\"xn-location\">Eastchester, NY<\/span> 10709<br \/>Phone: 914-206-9742<br \/>Email:\u00a0<a href=\"mailto:David@djslawllp.com\" target=\"_blank\" rel=\"nofollow\">David@djslawllp.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA57495&amp;sd=2025-04-03\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit---contact-the-djs-law-group-to-discuss-your-rights---mrvi-302420356.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit&#8212;contact-the-djs-law-group-to-discuss-your-rights&#8212;mrvi-302420356.html<\/a><\/p>\n<p>SOURCE  DJS Law Group LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA57495&amp;Transmission_Id=202504031821PR_NEWS_USPR_____LA57495&amp;DateId=20250403\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire LOS ANGELES , April 3, 2025 \/PRNewswire\/ &#8212; The DJS Law Group\u00a0reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (&#8220;Maravai&#8221; or &#8220;the Company&#8221;) (NASDAQ: MRVI) for violations of the federal securities laws. Shareholders who purchased the Company&#8217;s securities between August 7, 2024 and February 24, 2025, inclusive (the &#8220;Class Period&#8221;), are encouraged to contact the firm before May 5, 2025.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CASE DETAILS:\u00a0\u00a0The complaint alleges that the Company made false and misleading statements to the market concerning whether Maravai failed to maintain adequate internal controls over financial reporting. The Company improperly recognize revenue from certain transactions in fiscal 2024. The Company also allegedly overstated its goodwill. If you are a shareholder who suffered a loss,\u00a0contact &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; MRVI&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-833873","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LOS ANGELES , April 3, 2025 \/PRNewswire\/ &#8212; The DJS Law Group\u00a0reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (&#8220;Maravai&#8221; or &#8220;the Company&#8221;) (NASDAQ: MRVI) for violations of the federal securities laws. Shareholders who purchased the Company&#8217;s securities between August 7, 2024 and February 24, 2025, inclusive (the &#8220;Class Period&#8221;), are encouraged to contact the firm before May 5, 2025.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CASE DETAILS:\u00a0\u00a0The complaint alleges that the Company made false and misleading statements to the market concerning whether Maravai failed to maintain adequate internal controls over financial reporting. The Company improperly recognize revenue from certain transactions in fiscal 2024. The Company also allegedly overstated its goodwill. If you are a shareholder who suffered a loss,\u00a0contact &hellip; Continue reading &quot;MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; MRVI&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-03T22:24:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2657850\/DJS.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; MRVI\",\"datePublished\":\"2025-04-03T22:24:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/\"},\"wordCount\":269,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2657850\\\/DJS.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/\",\"name\":\"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2657850\\\/DJS.jpg\",\"datePublished\":\"2025-04-03T22:24:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2657850\\\/DJS.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2657850\\\/DJS.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; MRVI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/","og_locale":"en_US","og_type":"article","og_title":"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI - Market Newsdesk","og_description":"PR Newswire LOS ANGELES , April 3, 2025 \/PRNewswire\/ &#8212; The DJS Law Group\u00a0reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (&#8220;Maravai&#8221; or &#8220;the Company&#8221;) (NASDAQ: MRVI) for violations of the federal securities laws. Shareholders who purchased the Company&#8217;s securities between August 7, 2024 and February 24, 2025, inclusive (the &#8220;Class Period&#8221;), are encouraged to contact the firm before May 5, 2025.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CASE DETAILS:\u00a0\u00a0The complaint alleges that the Company made false and misleading statements to the market concerning whether Maravai failed to maintain adequate internal controls over financial reporting. The Company improperly recognize revenue from certain transactions in fiscal 2024. The Company also allegedly overstated its goodwill. If you are a shareholder who suffered a loss,\u00a0contact &hellip; Continue reading \"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; MRVI\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-03T22:24:15+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2657850\/DJS.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; MRVI","datePublished":"2025-04-03T22:24:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/"},"wordCount":269,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2657850\/DJS.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/","name":"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2657850\/DJS.jpg","datePublished":"2025-04-03T22:24:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2657850\/DJS.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2657850\/DJS.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mrvi-shareholders-have-opportunity-to-lead-the-maravai-lifesciences-holdings-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-mrvi-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; MRVI"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=833873"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833873\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=833873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=833873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=833873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}